Rifabutin
From Wikipedia, the free encyclopedia
Rifabutin
|
|
Systematic (IUPAC) name | |
(9S,12E,14S,15R,16S,17R,18R,19R,20S, 21S,22E,24Z)-6,16,18,20-tetrahydroxy-1'- isobutyl-14-methoxy-7,9,15,17,19,21,25- hepta-methyl-spiro[9,4-(epoxypentadeca [1,11,13]trienimino)-2H-furo-[2',3':7,8]-naphth [1,2-d]imidazol-2,4'-piperidin]-5,10,26-(3H,9H)- trione-16-acetate |
|
Identifiers | |
CAS number | 72559-06-9 |
ATC code | J04AB04 |
PubChem | 6323490 |
DrugBank | APRD00094 |
Chemical data | |
Formula | C46H62N4O11 |
Mol. weight | 847.005 g/mol |
Pharmacokinetic data | |
Bioavailability | 85% |
Protein binding | 85% |
Metabolism | Hepatic |
Half life | 28 to 62 hours (mean) |
Excretion | Renal and fecal |
Therapeutic considerations | |
Pregnancy cat. | |
Legal status | |
Routes | Oral |
Rifabutin is a bactericidal antibiotic drug primarily used in the treatment of tuberculosis. The drug is a semi-synthetic derivative of rifamycin S. Its effect is based on blocking the DNA-dependend RNA-polymerase of the bacteria. It is effective against Gram-positive and some Gram-negative bacteria, but also against the highly resistant Mycobacteria, e.g. Mycobacterium tuberculosis, M. leprae and M. avium intracellulare.
Contents |
[edit] History
Scientists at the Italian drug company Achifar discovered rifabutin in 1975. Eventually Archifar became part of Farmitalia Carlo Erba, a unit of the conglomerate Montedison. This company's Adria Laboratories subsidiary filed for Food and Drug Administration (FDA) approval of rifabutin under the brand name Mycobutin® in the early 1990s. The drug gained FDA approval in December 1992.
[edit] Other indications
Rifabutin is used in the treatment of mycobacterium avium complex disease, a bacterial infection most commonly encountered in late-stage AIDS patients.
[edit] Supply
Rifabutin is now sold in the U.S. market by Pfizer.
[edit] External links
Antimycobacterials (J04) edit | ||
---|---|---|
Tuberculosis: |
Aminosalicylic acid, Calcium aminosalicylate, Capreomycin, Cycloserine, Ethambutol, Ethionamide, Isoniazid, Morinamide, Protionamide, Pyrazinamide, Rifabutin, Rifampicin, Rifamycin, Rifapentin, Sodium aminosalicylate, Terizidone, Tiocarlide |
|
Leprosy: |